IMCD stock
Price history
+41.75% over the period1 year: from €74.78 (November 17, 2025) to €106.00 (November 16, 2026), +41.75%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 16, 2026 | €106.00 |
| October 30, 2026 | €102.25 |
| September 30, 2026 | €96.62 |
| August 31, 2026 | €100.10 |
| July 31, 2026 | €94.78 |
| June 30, 2026 | €79.00 |
| May 29, 2026 | €88.34 |
| April 30, 2026 | €100.15 |
| March 31, 2026 | €89.50 |
| February 27, 2026 | €81.40 |
| January 30, 2026 | €78.78 |
| December 31, 2025 | €77.34 |
| November 28, 2025 | €77.28 |
| November 17, 2025 | €74.78 |
At a glance
The company
Distribute specialty chemicals and ingredients globally across adhesives, coatings, personal care, food, pharmaceuticals, lubricants and energy sectors
Latest results
Quarter to June 30, 2026 · EPS €2.41
TickerLandia's take on IMCD
- Priced as usual relative to earnings: P/E on the latest fiscal year 29 vs a median of 30 over its last 10 fiscal years.
- Cheaper than similar companies: trailing 12-month P/E 27 vs 35 (−22%) in a group of 9.
- Strong point: Earnings stability (79/100 in its group). Weak point: Financial strength (27/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
+0.43% from the 52-week high
Analysts · 14 analysts
Average target€117.36+10.71% vs. price
Buy 11 · Hold 2 · Sell 1 · Buy
TickerLandia Fingerprint: IMCD
Compared with similar companies: high earnings stability, low financial strength, and strong momentum.
Financials and price compared with 59 companies in the specialty chemicals industry, worldwide. Momentum and risk compared with 1,160 European stocks.
Priceaverage52
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 27.0 54 Price/sales 1.13 34 Forward P/E 16.4 48 EV/EBITDA 14.3 62 Price/book 2.65 64 Profitabilitylow38
How much it earns on revenue and capital.
Metric Value Position in group Gross margin 25.0% 26 Net margin 4.6% 31 ROE 11.2% 50 ROA 5.2% 55 Operating margin 8.1% 26 Earnings stabilityhigh79
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 0.8% 92 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 65 Growthaverage49
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +1.30% 55 Revenue growth (year over year) +6.62% 36 Earnings growth (year over year) +10.05% 55 Financial strengthlow27
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Net debt/EBITDAcounts in reverse: lower means more financial strength 2.96 18 Interest coverage 5.85 36 Current ratio 1.35 26 Debt/equitycounts in reverse: lower means more financial strength 0.85 26 Dividendlow34
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years at least 12 years 19 Dividend yield 1.7% 38 Payout ratio 46.4% 46 Market momentumstrong69
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) +7.26% 72 Relative strength (6 months) −3.21% 51 1-year return +29.20% 73 Distance from 200-day average +15.84% 81 Risklow34
How much the price swings.
Metric Value Position in group Maximum drawdown (12 months) 26.4% 58 Volatility (60 days) 21.4% 26 Beta (1 year) 0.40 19
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
IMCD is priced as in the past and cheaper than similar companies
On the latest fiscal year's earnings (2025), IMCD's P/E today is 28.8, in line with the median of its last 10 fiscal years (30.1; between 21.0 and 53.6 from 2016 to 2025). IMCD's P/E (trailing 12 months): 27.0, −22% against the median of a group of 9 similar companies (34.6).
Compared with 9 similar companies
| Metric | IMCD | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 27.0 | Middle | |
| Forward P/E | 16.4 | Middle | |
| Operating margin | 8.1% | Middle | |
| ROE | 11.2% | Middle | |
| Debt/equity | 0.85 | High |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: IMCD. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
€2.65B
Latest quarter · Q2 2026
Net income
€142.34M
Latest quarter · Q2 2026
Quarterly net margin
5.4%
Latest quarter · Q2 2026
Numbers and valuation
Full valuation- Market cap
- €6.18B
- P/E
- 27.0
- EPS
- €3.90
- Volume
- 40.37K
- Daily trading
- €14.25M
- Dividend yield
- 1.71%
- Last ex-dividend on May 5, 2026
How IMCD is changing
All resultsRevenue grew 11.5% a year on average over the last 5 years
Operating margin fell from 10.4% to 8.2%
Profits turn into cash: free cash flow equal to 123% of net income
Returns
IMCD returns with dividends
€1,000 invested in IMCD 5 years ago, on November 16, 2021, would be worth €575 today with dividends reinvested: −42.48% in total, −10.47% per year. On price alone it would be €531 (−46.93%).
| Period | IMCD | AEX | €1,000 becomes |
|---|---|---|---|
| 1 month | +1.92% | +1.03% | €1,019 |
| 6 months | +10.39% | +12.92% | €1,104 |
| Year to date | +37.06% | +19.94% | €1,371 |
| 1 year | +44.31% | +20.69% | €1,443 |
| 3 years | −18.14% | +51.34% | €819 |
| 5 years | −42.48% | +38.05% | €575 |
| 10 years | +222.54% | +153.74% | €3,225 |
Over the last 6 months it has done better than 55% of the stocks in the Industrials sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. AEX: price only. Calculate your investment
The chart in detail
IMCD: technical analysis
IMCD is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 49.1% below its all-time closing high (€208.10, December 9, 2021).
- Trend
- Upward
- RSI (14 sessions)
- 65
- Between 30 and 70
- vs 200-session average
- +15.66%
Active signals
New 52-week high.
since November 13, 2026
Support and resistance
Price areas where IMCD has stopped several times in the last year. They describe the chart; they are not forecasts.
- No resistance above: the price is near the highs of the year
- Last price€106.00
- Support€105.30−0.66%3 touches, last on November 3, 2026
- Support€95.23−10.16%2 touches, last on September 7, 2026
- Support€93.29−11.99%6 touches, last on October 5, 2026
Volatility and risk
Over the last year it has moved little with the AEX.
- Beta (1 year) vs AEX
- 0.35
- Volatility (60 sessions, annualised)
- 21.0%
- Largest fall in the last year
- −26.43%
In session, November 16, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
IMCD: seasonality
Average monthly price change over 13 years
Over the last 13 years, the strongest month for IMCD has been July: +4.80% on average, positive in 10 years out of 13. The weakest has been June: −2.58% on average, positive in 3 years out of 12. November, the current month, has been positive in 7 years out of 12 (+2.31% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +0.03% | +1.09% | 7 of 12 |
| February | +1.24% | +1.23% | 6 of 12 |
| March | +1.62% | +1.48% | 7 of 12 |
| April | +3.28% | +4.19% | 8 of 12 |
| May | +1.05% | +2.73% | 8 of 12 |
| June | −2.58% | −4.55% | 3 of 12 |
| July | +4.80% | +4.64% | 10 of 13 |
| August | −0.06% | +1.00% | 7 of 13 |
| September | +0.11% | −0.96% | 6 of 13 |
| October | +1.69% | +2.25% | 8 of 13 |
| November | +2.31% | +1.91% | 7 of 12 |
| December | +2.48% | +0.51% | 7 of 12 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
IMCD and its competitors
Opening with its sales reach, IMCD N.V. distributes and sells specialty chemicals and ingredients in the Netherlands, the rest of Europe, the Middle East, Africa, North America, South America and Asia-Pacific. Its range covers additives, pigments, solvents, resins, surfactants, emulsifiers, fragrances, preservatives and silicones for coatings, plastics, rubber, personal care, food, detergents and lubricants, as well as base oils and fuel additives supplied to the oil, gas and energy sector.
- Headquarters
- Rotterdam, Netherlands
- Employees
- 5,237
- Founded
- 1995
- Chief executive
- Marcus Jordan
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| IMCDIMCD | $6.83B | 8.1% | 27.0 | +10.39% |
| Croda InternationalCRDA | $6.82B | 7.3% | 64.4 | +38.41% |
| SOLSOL | $6.62B | 15.1% | 34.6 | +11.68% |
| FUCHSFPE | $5.51B | 13.1% | 13.9 | +24.96% |
| BrenntagBNR | $9.36B | 5.3% | 22.3 | −5.44% |
| ArkemaAKE | $4.96B | 4.6% | 234.8 | −6.54% |
Same industry or related industries, similar size. Compare IMCD with its competitors · Full profile
